RIMINDER
DEAD

Serial Number

86283642

Owner

GOLDEN BIOTECHNOLOGY CORPORATION

Attorney

Jun-Hwa Jeong

Filing Date

May 16, 2014

Add to watchlist:

No watchlists yet
View on USPTO

RIMINDER Trademark

Serial Number: 86283642

RIMINDER is a trademark filed by GOLDEN BIOTECHNOLOGY CORPORATION on May 16, 2014. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently no longer active.

Owner Contact Info

GOLDEN BIOTECHNOLOGY CORPORATION (24 trademarks)

15F., NO.27-6, SEC. 2, JHONG-JHENG E RD.
TAIPEI COUNTY 25170 , TW

Entity Type: 03

Trademark Details

Filing Date

May 16, 2014

Registration Date

Not Registered

Goods & Services

Adjuvants for medical purposes; Antiallergic medicines; Anti-cancer preparations; Medicinal herbal extracts for medical purposes; Pharmaceutical and medicinal preparations and substances for the prevention and treatment of disorders of the nervous system, the immune system, the cardio-vascular system, the metabolic system, the respiratory system, the musculo-skeletal system, the genitourinary system, for the treatment of inflammatory disorders, ocular disorders, or bone diseases, for use in dermatology, oncology, hematology and ophthalmology and for gastroenterological disorders or liver ailments; Pharmaceutical and medicinal preparations for the treatment of brain diseases or disorders and autoimmune diseases or disorders; Dietary and nutritional supplements for medical use; Dietary supplements for treating fatigue or liver support; Animal feed additive for use as a nutritional supplement for medical purposes; Dietary supplements for human consumption or for animals; Nutritional additives for medical purposes for use in foods for human consumption or for animals; Animal feed supplements; Dietary pet supplements in the form of pet treats; Fungi preparations for medical or veterinary use for treating disorders of the nervous system, the immune system, the cardio-vascular system, the metabolic system, the respiratory system, the musculo-skeletal system, the genitourinary system, for the treatment of inflammatory disorders, ocular disorders, brain diseases or disorders, autoimmune diseases or disorders, or bone diseases, for use in dermatology, oncology, hematology and ophthalmology and for gastroenterological disorders or liver ailments. Pharmaceutical preparations and substances for veterinary purposes for treating disorders of the nervous system, the immune system, the cardio-vascular system, the metabolic system, the respiratory system, the musculo-skeletal system, the genitourinary system, for the treatment of inflammatory disorders, ocular disorders, brain diseases or disorders, autoimmune diseases or disorders, or bone diseases, for use in dermatology, oncology, hematology and ophthalmology and for gastroenterological disorders or liver ailments; Chemical preparations for medicinal purposes for treating disorders of the nervous system, the immune system, the cardio-vascular system, the metabolic system, the respiratory system, the musculo-skeletal system, the genitourinary system, for the treatment of inflammatory disorders, ocular disorders, brain diseases or disorders, autoimmune diseases or disorders, or bone diseases, for use in dermatology, oncology, hematology and ophthalmology and for gastroenterological disorders or liver ailments; Cardiovascular pharmaceuticals; Cardiovascular treatment preparations; Pharmaceuticals preparations for the treatment of kidney diseases

Filing History

ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Apr 7, 2015 MAB2
ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Apr 7, 2015 ABN2
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Sep 8, 2014 GNRN
NON-FINAL ACTION E-MAILED
Sep 8, 2014 GNRT
NON-FINAL ACTION WRITTEN
Sep 8, 2014 CNRT
ASSIGNED TO EXAMINER
Sep 2, 2014 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
May 30, 2014 NWOS
NEW APPLICATION ENTERED
May 20, 2014 NWAP